FRANKFURT – Ten to 20 million people in Germany suffer from obesity. This means that their body mass index is at least 30 kg/m2. ‘Obesity is a chronic disease that requires lifelong, interdisciplinary therapy and support for patients. The long-term perspective therefore plays a major role right from the start of treatment. It is important to know that temporary medical treatment carries a high risk of relapse,’ emphasises Professor Dr med. Dr h.c. Christian Wüster, Head of the Hormone and Metabolism Centre in Mainz. In his specialist practice, Christian Wüster also treats many patients from the Frankfurt area who suffer from obesity.
The guidelines of the German Obesity Society stipulate that patients should be treated from a BMI of 30. This is because above this threshold, the mortality rate of patients increases significantly. The risk of developing concomitant diseases such as hypertension, diabetes mellitus and an increased risk of stroke must be taken into account during treatment.
If these comorbidities are already present, obesity therapy is already indicated for overweight patients with a body mass index of 25 kg / m2 or more. For Professor Dr Dr h.c. Wüster, the treatment of patients with obesity is always an interdisciplinary challenge. He relies on a multimodal programme that combines exercise, nutrition and behavioural therapy.
As a specialist, the endocrinologist focuses on the effects of obesity on the hormonal balance and the interplay between hormonal diseases and the development of obesity. This is because obesity can also develop as a result of a metabolic disorder. The specialist knows that not all patients receive multimodal treatment in this form. Structured obesity therapy is an important prerequisite for helping patients to reduce and maintain their body mass index in the long term.